| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/30/2008 | CN101233104A Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101233103A Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101230067A Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 07/30/2008 | CN101230038A Pyridine carboxamide derivatives and their use as pesticides |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/30/2008 | CN101229166A Therapeutic agent for keratoconjunctival disorder |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405231 Oxidized thioether derivatives |
| 07/29/2008 | US7405228 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405215 e.g. [3-(3-benzyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-indol-1-yl]-acetic acid; inhibit binding of endogenous ligands, including prostaglandin PGD2 and its metabolites and certain thromboxane metabolites (such as 11-dehydro-TXB2), to CRTH2; antiallergent; asthma, bronchitis, rhinitis, cough, psoriasis |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/24/2008 | WO2008089005A2 Renin inhibitors |
| 07/24/2008 | WO2008087514A2 Hdac inhibitors |
| 07/24/2008 | WO2008086854A1 5-([1,3,4] oxadiazol-2-yl)-1h-indazol and 5-([1,3,4] thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 07/24/2008 | WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use |
| 07/24/2008 | WO2008068272A3 Antibacterial quinoline derivatives |
| 07/24/2008 | WO2008065626A3 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| 07/24/2008 | WO2008051406A3 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 07/24/2008 | WO2008032858A3 Thiadiazole compound and use thereof |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2007134169A9 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | WO2007077574A8 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177080 Oxazole derivatives of tetracyclines |
| 07/24/2008 | US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 07/24/2008 | US20080176911 2-{2-[2-hydroxy(3-methyl)butyrylamino]pentanoyl}amino-5-(1-methylethyl-4-(3-phenyl-1,2,4-oxadiazol-5-yl)thiazole; neurodegenerative diseases: senile dementia, Alzheimer's and Parkinson's diseases, Down's syndrome, amyloid angiopathy, cerebrovascular disorders, Pick's disease, post-traumatic dementias |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176865 Substituted arylpyrazoles |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | CA2712109A1 Thiazolidine derivatives and methods for the preparation thereof |
| 07/24/2008 | CA2675735A1 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and 5-(1,3,4-thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes |
| 07/23/2008 | EP1947098A1 Cyclic amine compounds and pest control agent |
| 07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945635A2 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 07/23/2008 | EP1945620A2 Compounds and compositions as ppar modulators |
| 07/23/2008 | EP1945617A2 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945029A2 Inhibitors of ion channels |
| 07/23/2008 | EP1615909B1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/23/2008 | EP1567489B1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | CN101228157A Amino acid salts of rosiglitazone |
| 07/23/2008 | CN101228156A Fungicidal carboxamides |
| 07/23/2008 | CN101228155A Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/23/2008 | CN101228154A Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 07/23/2008 | CN101228152A N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/23/2008 | CN101228143A Thiazole derivative |
| 07/23/2008 | CN101228134A Substituted arylpyrazoles as antiparasitic agent |
| 07/23/2008 | CN101228128A A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 07/23/2008 | CN100404544C 9-ketospinosyn derivatives |
| 07/23/2008 | CN100404511C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 07/23/2008 | CN100404505C Novel substituted indoles |
| 07/22/2008 | US7402704 Arylsulfones and uses related thereto |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402583 Substituted quinolines as antitumor agents |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402579 Quinobenzoxazine analogs and compositions |
| 07/22/2008 | US7402548 Benzoxazole compounds, process for producing the same and herbicides |
| 07/22/2008 | US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/22/2008 | CA2238171C Quinoline derivatives as nk3 antagonists |
| 07/17/2008 | WO2008085316A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | WO2008084873A1 Oxime derivative |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084671A1 Process for producing 1-substituted-2-pyridone-3-carboxylic acid derivative |
| 07/17/2008 | WO2008084218A1 Benzazole derivatives for the treatment of inflammations |
| 07/17/2008 | WO2008084043A1 Urea glucokinase activators |
| 07/17/2008 | WO2008063625A3 Pyridine compounds and methods of their use |
| 07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
| 07/17/2008 | WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 07/17/2008 | WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 07/17/2008 | WO2008020405A3 Azetidine compounds as orexin receptor antagonists |
| 07/17/2008 | WO2007146039A3 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171871 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide; Hepatitis C virus |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171733 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |